Stocks and Investing Stocks and Investing
Mon, June 22, 2015
Fri, June 19, 2015
Thu, June 18, 2015

Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $147 on, Jun 18th, 2015


Published on 2024-10-25 09:03:03 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $123 to $147 on, Jun 18th, 2015.

Christopher, nor any peers, have made any analyst calls on BMRN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources